We're seeing a repeat cycle for biotech stocks, Jim Cramer told viewers of
"Stop Trading" segment Monday.
is up on the day, but "
is my favorite," said Cramer.
Cramer said we are seeing the same "trade into the highest-growth biotech names" that we did in 1990, and the cycle is "happening again." He also urged people to notice that "we're seeing big bets being made for the third quarter" and that "biotech is the most visible bet."
Turning to supermarkets, Cramer offered his take on
. Despite saying it's being the "least forward thinking" of the major supermarkets, he said, Kroger's stock is "flirting with 52-week highs." Furthermore, he endorsed the money going into Kroger, saying it "wasn't as bad as it used to be" mostly because "management is really good now."
Noting that supermarkets had "very good margins," Cramer summarized by saying that
was a "value play" and noting that
had been downgraded.
At the time of publication, Cramer had no positions in stocks mentioned.
Jim Cramer is a director and co-founder of TheStreet.com. He contributes daily market commentary for TheStreet.com's sites and serves as an adviser to the company's CEO. Outside contributing columnists for TheStreet.com and RealMoney.com, including Cramer, may, from time to time, write about stocks in which they have a position. In such cases, appropriate disclosure is made. To see his personal portfolio and find out what trades Cramer will make before he makes them, sign up for
Action Alerts PLUS. Watch Cramer on "Mad Money" weeknights on CNBC. Click
here to order Cramer's latest book, "Mad Money: Watch TV, Get Rich," click
here to order his book, "Real Money: Sane Investing in an Insane World," click
here to get his second book, "You Got Screwed!" and click
here to order Cramer's autobiography, "Confessions of a Street Addict." While he cannot provide personalized investment advice or recommendations, he invites you to send comments on his column by
TheStreet.com has a revenue-sharing relationship with Traders' Library under which it receives a portion of the revenue from Traders' Library purchases by customers directed there from TheStreet.com.